«Immunization

Below is an extended Immunization patents listing. Click here to return to the Immunization main in depth entry.

Patents :
US Patent No.	Title
7417126	PRO246 antibodies
7419665	Monoclonal antibodies for detection of urinary trypsin inhibitors
7419668	Vaccine to control equine protozoal myeloencephalitis in horses
7419669	Peptide epitopes common to antigens of the same multigene family
7419670	Method of treating arthritis with SERP-1 and an immunosuppressant
7419671	P. gingivalis antigenic composition
7419674	Alpha virus-based cytomegalovirus vaccines
7419779	Modulators of angiogenesis
7419789	Method of inhibiting binding of Dengue virus to a human cell with DC-SIGN blockers
7419791	Methods of screening compounds using a T1R3 hetero-oligomeric taste receptor
7419796	Method of making a test device
7419664	Method of treatment using antibody to CLCA-1
7419663	Treatment of complement-associated disorders
7419660	Vaccines for treatment of lymphoma and leukemia
7417127	Antibodies specific for CD44v6
7417128	7C10 and 16C10 CD80-specific antibodies
7417136	Nucleic acid vaccines for prevention of flavivirus infection
7418416	Gamma trading tool
7418633	Method and apparatus for immunizing applications on a host server from failover processing within a switch
7418981	System for dispensing biological fluids
7419482	Systems and methods for delivering agents into targeted tissue of a living being
7419504	Poly(ester amide) block copolymers
7419657	Treatment of atherosclerotic disorders
7419658	Isolated ligand of ChemerinR
7419799	Compositions and methods for the treatment of immune related diseases
7419806	Immunogenic Mycoplasma hyopneumoniae polypeptides
7420041	Cytotoxicity mediation of cells evidencing surface expression of TROP-2
7420042	Soluble neuropilin/growth factor receptor fusion proteins
7420043	Reagents for detecting efavirenz
7420044	Nucleic acid and protein homologs and uses thereof
7420045	IAPs associated cell cycle proteins, compositions and methods of use
7420046	Sequence-determined DNA fragments encoding RNA polymerase proteins
7420047	Non-anaphylactogenic IgE fusion proteins
7420049	Sequence-determined DNA fragments encoding AP2 domain proteins
7420099	Transgenic animals and uses thereof
7420100	Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression
7420040	Cytotoxicity mediation of cells evidencing surface expression of TROP-2
7420039	Individualized anti-cancer antibodies
7420038	Compositions for controlling hair growth
7419807	Chlamydia protein, gene sequence and uses thereof
7419811	Use of specifically engineered enzymes to enhance the efficacy of prodrugs
7419816	Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
7419824	BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof
7419956	Isolated physiologically active peptide and use thereof
7419957	Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
7420030	Aminopeptidase A (APA) targeting peptides for the treatment of cancer
7420033	Composition of lactoferrin related peptides and uses thereof
7420034	HLA-A24-restricted cancer antigen peptides
7420037	Heat shock protein-based vaccines and immunotherapies
7421347	Identifying oligonucleotides for in vitro recombination

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.